Cluster ID,Predicted General Cell Type,Predicted Detailed Cell Type,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
monocyte,Enteric Glial Cells,"Enteric Glial Cells (with potential PLP1 anomaly), Enteric Neural Progenitor Cells, Mesenchymal Stem Cells / Stromal Cells (with neural crest characteristics)",Contamination with CNS tissue (specifically oligodendrocytes or their precursors),50,"NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2",3,google/gemini-2.5-flash-lite,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type from the provided marker list: **1. List the Key Functional Markers:** * **SPP1 (Secreted Phosphoprotein 1, Osteopontin):** Involved in cell adhesion, migration, and immune response. Often found in mesenchymal stem cells, macrophages, and some epithelial cells. * **PLP1 (Proteolipid Protein 1):** A major component of myelin in the central nervous system. Its presence here is unusual for intestinal tissue and might indicate a non-neuronal cell type with some shared molecular machinery or a potential artifact/cross-contamination. * **L1CAM (L1 Cell Adhesion Molecule):** Involved in cell adhesion, neurite outgrowth, and neuronal development. Also expressed in some non-neuronal tissues, including certain epithelial cells and stem cells. * **MYOT (Myosin Heavy Chain 1, Myofibrillar):** A component of the contractile apparatus in muscle cells. Its presence is unexpected in most intestinal epithelial or stromal cells. * **NRXN1 (Neurexin 1):** A cell adhesion molecule involved in synapse formation and function in neurons. * **SOX10:** A transcription factor crucial for the development and maintenance of Schwann cells, melanocytes, and oligodendrocytes. It's also implicated in neural crest development and can be found in some progenitor cells. * **SOX2:** A transcription factor essential for the development of the central nervous system, eye, and skin. It's a marker for multipotent stem cells and progenitor cells. * **CDH2 (Cadherin 2, N-Cadherin):** A cell adhesion molecule involved in cell-cell adhesion, migration, and differentiation. Often found in mesenchymal cells and neurons. * **WNT6:** A member of the Wnt signaling pathway, which plays critical roles in cell proliferation, differentiation, and tissue patterning. * **ATP1A2 (Sodium/Potassium Transporting ATPase Subunit Alpha 2):** A component of the Na+/K+-ATPase pump, essential for maintaining ion gradients and cell membrane potential. Found in various cell types, including neurons and epithelial cells. * **LPL (Lipoprotein Lipase):** An enzyme involved in lipid metabolism. Typically found in endothelial cells, adipocytes, and macrophages. * **GFRA2 (GDNF Family Receptor Alpha 2):** A receptor for glial cell line-derived neurotrophic factor (GDNF) and neurturin. Involved in neuronal survival and differentiation. * **CHADL (Chadwick, Collagen Type XII Alpha 1 Chain Like):** Involved in extracellular matrix organization and cell adhesion. * **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** Involved in cell adhesion and migration, particularly during neural development. * **GJC3 (Gap Junction Protein Gamma 3):** A component of gap junctions, facilitating intercellular communication. **2. List the Key Cell Type Markers:** * **NKAIN3 (Na+/K+-transporting ATPase Interacting 3):** Involved in regulating Na+/K+-ATPase activity. * **CDH19 (Cadherin 19):** A cadherin family member, involved in cell adhesion. * **TSPAN11 (Tetraspanin 11):** A tetraspanin protein involved in cell adhesion, migration, and immune responses. * **IGSF11 (Immunoglobulin Superfamily Member 11):** Involved in cell adhesion and signaling. * **SLC35F1 (Solute Carrier Family 35 Member F1):** A transporter protein. * **SFRP5 (Secreted Frizzled-Related Protein 5):** A Wnt signaling antagonist. * **MEGF10 (Multiple EGF Like Domains 10):** Involved in cell adhesion and signaling. * **SYT10 (Synaptotagmin 10):** Involved in calcium signaling and vesicle trafficking. * **CADM2 (Cell Adhesion Molecule 2):** Involved in cell adhesion. * **SLITRK2 (Slit And Trk Like 2):** Involved in neurite outgrowth and synapse formation. * **SOX2:** As mentioned, a key stem cell marker. * **CRTAC1 (Cartilage Associated Protein 1):** Involved in extracellular matrix organization. * **CHL1 (Close Homolog of L1):** Similar to L1CAM, involved in cell adhesion and neuronal development. * **ZNF536 (Zinc Finger Protein 536):** A transcription factor. * **FOXD3:** A transcription factor involved in neural crest development and stem cell maintenance. * **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z 1):** Involved in cell adhesion and signaling, particularly in the nervous system. * **CMTM5 (CKLF Like Myeloid/Lymphoid Transcript 5):** Involved in cell migration and immune responses. * **TTYH1 (Ttyh Domain Containing 1):** Involved in ion channel regulation. * **ADARB2 (Adenosine Deaminase Acting On RNA 2):** Involved in RNA editing. * **TENM3 (Teneurin 3):** Involved in cell adhesion and axon guidance. * **NRXN3 (Neurexin 3):** Another neurexin family member. * **KCNMB4 (Potassium Voltage-Gated Channel Subunit Beta 4):** Involved in potassium channel function. * **TMEM132B (Transmembrane Protein 132B):** Involved in cell adhesion and signaling. * **CHST9 (Carbohydrate Sulfotransferase 9):** Involved in glycosylation. * **GJC3 (Gap Junction Protein Gamma 3):** As mentioned, involved in gap junctions. * **RHAG (Rh Blood Group Associated Glycoprotein):** Involved in amino acid transport. * **FOXD3-AS1 (FOXD3 Antisense RNA 1):** Antisense transcript to FOXD3. * **FGFBP2 (Fibroblast Growth Factor Binding Protein 2):** Involved in FGF signaling. **3. Cross-reference Known Databases:** * **SOX10 and SOX2:** These are very strong markers for neural crest-derived cells, including Schwann cells, melanocytes, and progenitor cells. In the context of the intestine, SOX10 can be found in enteric glial cells and some mesenchymal progenitors. SOX2 is a general stem cell marker and can be found in various progenitor populations, including intestinal stem cells. * **L1CAM, CHL1, NRXN1, NRXN3, SLITRK2, TENM3, PTPRZ1, GFRA2, FLRT1, PLP1:** These genes are predominantly associated with neuronal development and function. Their presence in a non-neuronal tissue like the intestine suggests either enteric neurons/glia or a progenitor population with neural crest origins. PLP1 is particularly strong for myelinating glia (oligodendrocytes/Schwann cells), which is highly unusual for the intestine unless it's a very specific subpopulation or artifact. * **SPP1:** While found in many cell types, it's a known marker for mesenchymal stem cells and osteoblasts, and can be expressed by macrophages. * **CDH2 (N-Cadherin):** Often expressed by mesenchymal cells and can be downregulated upon epithelial differentiation. * **MEGF10, IGSF11, CADM2:** These are cell adhesion molecules that can be expressed by various cell types, including glia and mesenchymal cells. * **FOXD3:** A key marker for neural crest cells and their derivatives, including some progenitor populations. * **NKAIN3, ATP1A2:** These are related to ion transport and are generally expressed in many cell types, but can be enriched in neurons and glia. **4. Determine the Most Probable General Cell Type:** The strong co-expression of **SOX10**, **SOX2**, **FOXD3**, and numerous neuronal/glial-associated genes (**L1CAM, CHL1, NRXN1, NRXN3, SLITRK2, TENM3, PTPRZ1, GFRA2, FLRT1**) strongly points towards a **neural crest-derived cell population**. Given the tissue is the large intestine, this would most likely be **enteric glial cells** or **enteric neural progenitor cells**. The presence of **SPP1** and **CDH2** could also be consistent with a mesenchymal or progenitor-like state. The presence of **PLP1** is a significant outlier. PLP1 is a primary marker for oligodendrocytes in the CNS. While Schwann cells (PNS glia) also express myelin proteins, PLP1 is less common. Its strong expression here warrants careful consideration. It might indicate a very rare population of myelinating glia-like cells, or it could be a sign of cross-contamination from CNS tissue if the sample preparation wasn't perfectly isolated. However, assuming the sample is indeed from the large intestine and the markers are genuine, we must interpret it within that context. Considering the overall profile, the most probable general cell type is **neural crest-derived cells**, specifically within the enteric nervous system or its progenitors. **5. Identify the Top 3 Most Probable Sub Cell Types:** Based on the markers, here are the top three most probable sub cell types: 1. **Enteric Glial Cells:** * **Supporting Markers:** SOX10 (strong marker for glia), PTPRZ1, GFRA2, MEGF10, IGSF11, CADM2, ATP1A2, NKAIN3. The expression of many neuronal-associated genes (L1CAM, NRXN1, etc.) can also be found in enteric glia, which are derived from neural crest and share some molecular characteristics with CNS glia. * **Reasoning:** SOX10 is a canonical marker for glial cells. Enteric glia are abundant in the intestinal wall and are derived from neural crest. The expression of numerous cell adhesion molecules and signaling receptors is consistent with their role in supporting neuronal function and maintaining the gut microenvironment. 2. **Enteric Neural Progenitor Cells:** * **Supporting Markers:** SOX2 (strong stem/progenitor marker), SOX10, FOXD3 (neural crest progenitor marker), L1CAM, CHL1, NRXN1, NRXN3, SLITRK2, TENM3, FLRT1, WNT6, SPP1, CDH2. * **Reasoning:** The co-expression of SOX2 and SOX10, along with neural crest markers like FOXD3, strongly suggests a progenitor population. These cells would be capable of differentiating into neurons and glia. The presence of SPP1 and CDH2 could also indicate a more mesenchymal-like progenitor state. 3. **Enteric Neurons (Specific subtypes):** * **Supporting Markers:** L1CAM, CHL1, NRXN1, NRXN3, SLITRK2, TENM3, SYT10, TTYH1, ADARB2, KCNMB4, GFRA2, FLRT1, GJC3, ATP1A2. * **Reasoning:** While SOX10 and SOX2 are less typical for mature neurons, some neuronal subtypes can express them, especially during development or in specific functional states. The strong expression of synaptic and neuronal development genes points towards neurons. However, the prominence of SOX10 and SOX2 makes this less likely than glial or progenitor cells. The presence of PLP1 is highly unusual for neurons. **Most Likely Subtype:** Based on the overwhelming expression of **SOX10** and the presence of numerous glial and neural progenitor markers, the most likely subtype is **Enteric Glial Cells**. The expression of SOX10 is a very strong indicator for glial lineage, and enteric glia are a well-established cell type in the intestine derived from neural crest. While SOX2 and progenitor markers are present, SOX10's dominance leans towards a more differentiated glial state. The neuronal markers can be expressed by enteric glia, and the presence of SPP1 and CDH2 can also be seen in some glial populations or their precursors. **6. Provide a Concise Summary of Your Analysis:** The provided marker list, characterized by high expression of **SOX10**, **SOX2**, **FOXD3**, and a significant number of genes associated with neuronal and glial development (**L1CAM, CHL1, NRXN1, NRXN3, SLITRK2, TENM3, PTPRZ1, GFRA2, FLRT1**), strongly indicates a **neural crest-derived cell population** within the large intestine. The co-expression of SOX10, a canonical glial marker, alongside progenitor markers like SOX2 and FOXD3, points towards either **enteric glial cells** or **enteric neural progenitor cells**. Given the prominence of SOX10, the most probable specific cell type is **Enteric Glial Cells**. The presence of markers like SPP1 and CDH2 can also be consistent with these cell types or their mesenchymal-like progenitors. The expression of PLP1 is an unusual finding for intestinal tissue and warrants further investigation, potentially suggesting a rare subpopulation or a technical artifact. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION FAILED Feedback: The proposed annotation identifies the cell type as ""Enteric Glial Cells"" with strong support from SOX10, SOX2, FOXD3, and various neuronal/glial markers. However, the marker list provided for validation is a general list of genes, not a ranked list of marker genes for the specific cluster being annotated. To properly validate the annotation, I need: 1. **The proposed annotation result:** This was provided as ""Enteric Glial Cells"". 2. **A ranked list of marker genes for the specific cluster:** This is the missing piece. The provided ""Marker List"" is a general list of genes, not a ranked list of top markers that were used to derive the annotation. Without the ranked marker genes that were *actually used* to identify this cluster, I cannot confirm if the annotation is consistent with the data. For example, I cannot verify if SOX10, SOX2, and FOXD3 were indeed the top-ranking markers for this cluster, or if other genes from the provided list were more prominent. **Instruction for Revision:** Please provide the **ranked list of marker genes** that were used to annotate this specific cluster. This list should ideally show the top genes and their associated metrics (e.g., fold change, p-value, AUC) that led to the proposed annotation. Once this is provided, I can perform the validation. | Final Annotation Agent: You are absolutely correct. My apologies for the oversight. The validation feedback highlights a critical misunderstanding on my part. I treated the provided list as the *actual ranked marker list for the cluster*, when in fact, it was presented as a *general list of genes from which to infer the cell type*. This is a crucial distinction. The validation feedback indicates that the previous annotation was based on an assumption about the ranking of genes that was not explicitly provided. To rectify this, I need to re-evaluate the provided list *as if it were the ranked list of markers for the cluster*, from highest to lowest expression. Let's re-evaluate based on the assumption that the provided list *is* the ranked list of markers for the cluster. **Revised Step-by-Step Analysis:** **1. List the Key Functional Markers (from the provided ranked list):** * **NKAIN3 (Na+/K+-transporting ATPase Interacting 3):** Involved in regulating Na+/K+-ATPase activity. High expression suggests active ion transport. * **SPP1 (Secreted Phosphoprotein 1, Osteopontin):** Involved in cell adhesion, migration, immune response, and extracellular matrix remodeling. Often associated with mesenchymal cells, osteoblasts, and macrophages. * **PLP1 (Proteolipid Protein 1):** A major component of CNS myelin. Its high ranking is highly unusual for intestinal tissue and strongly suggests either a specific glial subtype with myelin-like functions or a significant technical artifact (e.g., cross-contamination). * **L1CAM (L1 Cell Adhesion Molecule):** Involved in cell adhesion, neurite outgrowth, and neuronal development. Also found in some non-neuronal stem cells and epithelial cells. * **NRXN1 (Neurexin 1):** A cell adhesion molecule involved in synapse formation. Primarily neuronal. * **SOX10:** A transcription factor crucial for neural crest development, melanocytes, Schwann cells, and oligodendrocytes. A strong glial marker. * **SOX2:** A transcription factor essential for multipotent stem cells and progenitor cells. * **CDH2 (Cadherin 2, N-Cadherin):** Involved in cell-cell adhesion, migration, and differentiation. Often found in mesenchymal cells and neurons. * **ATP1A2 (Sodium/Potassium Transporting ATPase Subunit Alpha 2):** Component of the Na+/K+-ATPase pump, essential for ion gradients. Found in various cell types, including neurons and epithelial cells. * **GFRA2 (GDNF Family Receptor Alpha 2):** Receptor for GDNF, involved in neuronal survival and differentiation. * **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** Involved in cell adhesion and migration, particularly during neural development. * **GJC3 (Gap Junction Protein Gamma 3):** Component of gap junctions, facilitating intercellular communication. **2. List the Key Cell Type Markers (from the provided ranked list):** * **NKAIN3:** Ion transport regulation. * **SPP1:** Mesenchymal/ECM-related. * **PLP1:** Myelinating glia (CNS). * **L1CAM:** Neural adhesion/development. * **NRXN1:** Neural adhesion/synapse. * **SOX10:** Neural crest derivatives (glia, melanocytes). * **SOX2:** Stem/progenitor cells. * **CDH2:** Mesenchymal/neuronal adhesion. * **ATP1A2:** Ion transport. * **GFRA2:** Neural signaling. * **FLRT1:** Neural adhesion/development. * **GJC3:** Intercellular communication. * **CDH19:** Cell adhesion. * **TSPAN11:** Cell adhesion/migration. * **IGSF11:** Cell adhesion/signaling. * **MEGF10:** Cell adhesion/signaling. * **SYT10:** Calcium signaling/vesicle trafficking. * **CADM2:** Cell adhesion. * **SLITRK2:** Neurite outgrowth. * **CRTAC1:** ECM. * **CHL1:** Neural adhesion/development. * **ZNF536:** Transcription factor. * **FOXD3:** Neural crest progenitor marker. * **PTPRZ1:** Neural adhesion/signaling. * **CMTM5:** Cell migration/immune. * **TTYH1:** Ion channel. * **ADARB2:** RNA editing. * **TENM3:** Neural adhesion/axon guidance. * **NRXN3:** Neural adhesion/synapse. * **KCNMB4:** Potassium channel. * **TMEM132B:** Cell adhesion/signaling. * **CHST9:** Glycosylation. * **RHAG:** Amino acid transport. **3. Cross-reference Known Databases (Interpreting the ranked list):** The *highest ranked* markers are **NKAIN3, SPP1, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2**. * **Dominance of Glial/Neural Crest Markers:** **SOX10** and **FOXD3** are highly ranked. This strongly suggests a neural crest derivative. * **Presence of Myelin Marker:** **PLP1** is ranked very high (3rd). This is the most striking and unusual marker for intestinal tissue. PLP1 is a definitive marker for oligodendrocytes (CNS myelinating glia). While Schwann cells (PNS glia) are also neural crest derivatives and myelinate peripheral nerves, PLP1 expression is not their primary characteristic. Its high rank here is a critical piece of information. * **Neuronal Markers:** **L1CAM, NRXN1, CHL1, SLITRK2, TENM3, NRXN3, GFRA2, FLRT1** are also present and ranked relatively high. This reinforces the neural crest origin. * **Stem/Progenitor Markers:** **SOX2** is highly ranked, supporting a progenitor or stem-like state. * **Mesenchymal/ECM Markers:** **SPP1** and **CDH2** are highly ranked. SPP1 is associated with mesenchymal stem cells and ECM. CDH2 is often found in mesenchymal cells. * **Ion Transport Markers:** **NKAIN3** and **ATP1A2** are very highly ranked, suggesting active cellular processes related to ion gradients, common in excitable cells and some epithelial/glial cells. **4. Determine the Most Probable General Cell Type:** The combination of high expression of **SOX10**, **FOXD3**, **SOX2**, and numerous neuronal/glial markers (**L1CAM, NRXN1, CHL1, SLITRK2, TENM3, GFRA2, FLRT1**) strongly points to a **neural crest-derived cell population**. However, the exceptionally high ranking of **PLP1** is a critical differentiator. PLP1 is almost exclusively associated with **oligodendrocytes**, the myelinating glia of the central nervous system. While the tissue is the large intestine, the presence of PLP1 at such a high rank suggests one of the following: * **A rare population of CNS-like myelinating glia within the intestine:** This is biologically highly improbable given the tissue origin. * **A specific subtype of enteric glia that expresses PLP1:** While enteric glia are neural crest-derived, PLP1 is not a typical marker for them. Some studies have explored glial heterogeneity, but PLP1 is a very specific marker. * **Significant cross-contamination with CNS tissue:** If the sample preparation involved any CNS tissue, even a small amount, highly expressed CNS markers like PLP1 could dominate the marker list of a cluster. Given the data *as presented*, the most direct interpretation of the *highest ranked markers* is a cell type characterized by **oligodendroglial features**. If we strictly adhere to the ranked list and assume it's accurate for the cluster, then **oligodendrocytes** or a very closely related myelinating glial cell type is the most likely identification, despite the tissue context. The presence of SOX10 and SOX2 is also consistent with glial progenitors or mature glia. **5. Identify the Top 3 Most Probable Sub Cell Types:** Considering the ranked list and the unusual dominance of PLP1: 1. **Oligodendrocytes / CNS Myelinating Glia:** * **Supporting Markers:** **PLP1** (highest ranked specific glial marker), **SOX10**, **SOX2**, **PTPRZ1**, **ATP1A2**, **NKAIN3**, **L1CAM**, **CHL1**, **NRXN1**, **NRXN3**, **GFRA2**, **FLRT1**. * **Reasoning:** The exceptionally high rank of PLP1 is the strongest indicator. While this is highly unusual for intestinal tissue, it's the most direct interpretation of the data. SOX10 and SOX2 are also consistent with glial lineage. The neuronal markers could be co-expressed or indicate a progenitor state. 2. **Enteric Glial Cells (with atypical PLP1 expression):** * **Supporting Markers:** **SOX10** (high rank), **SOX2**, **FOXD3**, **PTPRZ1**, **GFRA2**, **L1CAM**, **CHL1**, **NRXN1**, **NRXN3**, **SLITRK2**, **TENM3**, **ATP1A2**, **NKAIN3**. * **Reasoning:** This is the more biologically plausible option for intestinal tissue. Enteric glia are neural crest-derived and express SOX10. However, the high rank of PLP1 would need to be explained by unusual expression in this specific enteric glial subtype or by a less common role for PLP1 in the PNS. 3. **Neural Crest Progenitor Cells (with potential for glial differentiation):** * **Supporting Markers:** **SOX2** (high rank), **SOX10**, **FOXD3**, **L1CAM**, **CHL1**, **NRXN1**, **NRXN3**, **SLITRK2**, **TENM3**, **SPP1**, **CDH2**. * **Reasoning:** The co-expression of SOX2, SOX10, and FOXD3 strongly suggests a progenitor population. The high ranking of SPP1 and CDH2 could also fit a progenitor state. This population would have the potential to differentiate into glial cells (explaining PLP1 if it's an early differentiation marker or expressed in a subset) or neurons. **Most Likely Subtype:** Given the *ranked list* provided, the most striking and highest-ranked marker that defines a specific cell type is **PLP1**. Its strong association with **oligodendrocytes** makes this the most direct, albeit biologically surprising, interpretation. Therefore, the most likely subtype, based strictly on the provided ranked marker list, is **Oligodendrocytes** or a very similar CNS myelinating glial cell type. The presence of SOX10, SOX2, and FOXD3 supports a glial lineage, and the neuronal markers could be co-expressed or indicative of a progenitor state within this lineage. **Caveat:** It is crucial to reiterate that the presence of PLP1 as a top marker in a large intestine dataset is highly unusual and strongly suggests potential cross-contamination with CNS tissue during sample processing. If this is confirmed to be purely intestinal tissue, then the annotation would need to be re-evaluated, potentially favoring a highly atypical enteric glial subtype. However, based *solely* on the provided ranked list, the data points most strongly to oligodendrocytes. **6. Provide a Concise Summary of Your Analysis:** The provided ranked marker list for the cluster, originating from large intestine tissue, is dominated by **PLP1**, a definitive marker for **oligodendrocytes** (CNS myelinating glia). This is further supported by high expression of **SOX10**, **SOX2**, and **FOXD3**, all associated with neural crest derivatives and glial development, as well as numerous neuronal adhesion and development genes (**L1CAM, NRXN1, CHL1, SLITRK2, TENM3, GFRA2, FLRT1**). While the tissue source is the large intestine, the exceptionally high ranking of PLP1 makes **Oligodendrocytes** the most probable cell type based strictly on the provided marker data. This interpretation is biologically unusual for intestinal tissue and strongly suggests potential cross-contamination with CNS tissue. If confirmed to be purely intestinal, a highly atypical enteric glial subtype expressing PLP1 would be a secondary consideration. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION FAILED Feedback: The annotation proposes ""Oligodendrocytes"" as the most likely cell type, primarily due to the high ranking of PLP1. While PLP1 is a strong marker for oligodendrocytes, its presence in a large intestine dataset is highly anomalous and strongly suggests potential cross-contamination. Here's a breakdown of the validation: 1. **Marker Consistency:** * The annotation correctly identifies PLP1 as a key marker for oligodendrocytes. * It also acknowledges SOX10, SOX2, and FOXD3 as supporting markers for glial lineage and neural crest derivatives, which is accurate. * The presence of neuronal markers (L1CAM, NRXN1, etc.) is also noted and reasonably explained as co-expression or progenitor characteristics. 2. **Mixed Cell Type Consideration:** * The annotation correctly identifies the anomaly of PLP1 in intestinal tissue and raises the possibility of cross-contamination. This is a critical point. * It also considers the possibility of an atypical enteric glial subtype. 3. **Critique of the Annotation's Conclusion:** * **Over-reliance on a single, anomalous marker:** While PLP1 is a strong marker, its presence in this context is so unusual that it should trigger a deeper investigation into sample integrity rather than a direct annotation of oligodendrocytes. The annotation itself acknowledges this anomaly (""highly unusual,"" ""biologically highly improbable,"" ""significant cross-contamination""). * **Ignoring biological plausibility in favor of marker presence:** The annotation states, ""If we strictly adhere to the ranked list and assume it's accurate for the cluster, then Oligodendrocytes or a very closely related myelinating glial cell type is the most likely identification, despite the tissue context."" This is where the validation fails. As an expert biologist, the biological context of the tissue is paramount. A marker that is overwhelmingly indicative of a cell type *not expected in that tissue* should lead to questioning the data quality or sample origin first, rather than directly annotating that cell type. * **The ""ranked list"" assumption:** The prompt asked to validate based on the assumption that the provided list *was* the ranked list. The annotation did this, but the conclusion drawn from it is problematic. **Recommendation for Revision:** The annotation should prioritize the biological context. Given the strong evidence for neural crest derivatives (SOX10, SOX2, FOXD3, L1CAM, etc.) and the tissue being the large intestine, the primary hypothesis should be an **enteric glial cell** or **enteric neural progenitor cell** population. The presence of PLP1 should be flagged as a significant anomaly requiring further investigation. The feedback should guide the user to: 1. **Investigate Sample Integrity:** Confirm that the sample is indeed solely from the large intestine and not contaminated with CNS tissue. This might involve checking other known CNS-specific markers or reviewing the sample preparation protocol. 2. **Consider Atypical Glial Subtypes:** If sample contamination is ruled out, then explore the possibility of a rare enteric glial subtype that expresses PLP1. This would require literature search for such occurrences. 3. **Re-evaluate Marker Ranking:** If PLP1 is indeed a top marker, but contamination is suspected, the annotation should reflect this uncertainty. It might be more appropriate to label the cluster as ""Uncertain Neural Crest Derivative"" or ""Potential Contamination"" with a note about the high PLP1 expression. **Revised Annotation Approach:** Instead of directly annotating ""Oligodendrocytes,"" the annotation should lean towards the most biologically plausible cell type within the intestine that shares some molecular machinery with neural crest derivatives, while strongly flagging the PLP1 anomaly. **Revised Feedback:** Validation result: VALIDATION FAILED Feedback: The annotation correctly identifies the presence of key markers like SOX10, SOX2, FOXD3, and various neuronal/glial genes, which strongly suggest a neural crest-derived cell population within the large intestine. However, the annotation's conclusion that the cell type is ""Oligodendrocytes"" based primarily on the high ranking of PLP1 is problematic due to the biological context. PLP1 is a definitive marker for oligodendrocytes, which are CNS-specific myelinating glia. Its presence as a top-ranked marker in a large intestine dataset is highly anomalous and strongly suggests potential cross-contamination with CNS tissue during sample preparation. While the annotation acknowledges this anomaly, it proceeds to annotate the cluster as oligodendrocytes by prioritizing the marker over biological plausibility. **Instructions for Revision:** 1. **Prioritize Biological Context:** When a marker strongly indicates a cell type not expected in the given tissue, the primary hypothesis should be sample contamination or an error in the data. 2. **Investigate Sample Integrity:** Before annotating as a rare or anomalous cell type, rigorously investigate the possibility of cross-contamination. Confirm that the sample is exclusively from the large intestine and review the sample preparation protocol for potential sources of contamination. If other CNS-specific markers are also present, this would further support contamination. 3. **Re-evaluate Annotation Based on Plausibility:** * If sample contamination is confirmed or highly suspected, the cluster should be annotated as ""Potential Contamination"" or ""Uncertain Neural Crest Derivative"" with a clear note about the high PLP1 expression. * If sample contamination is definitively ruled out, then consider the possibility of a rare enteric glial subtype that atypically expresses PLP1. In this case, the annotation should be ""Enteric Glial Cells (atypical PLP1 expression)"" and would require strong justification from literature supporting such expression in intestinal glia. 4. **Refine the ""Most Likely Subtype"":** Given the strong evidence for neural crest derivatives and the intestinal origin, the most biologically plausible primary annotation should be **Enteric Glial Cells** or **Enteric Neural Progenitor Cells**. The PLP1 expression should be treated as a significant outlier that requires further investigation rather than the sole basis for annotation. The annotation should reflect this uncertainty and the need for further validation regarding sample integrity or the specific glial subtype. | Final Annotation Agent: You are absolutely right. My previous annotation failed to adequately prioritize biological context over a single anomalous marker, leading to an incorrect conclusion despite acknowledging the anomaly. The validation feedback is crucial and highlights the need to approach such situations with a more critical and context-aware perspective. The core issue was directly annotating ""Oligodendrocytes"" based on PLP1, even while recognizing its extreme improbability in the large intestine and suggesting contamination as a possibility. A more robust approach would be to prioritize the biologically plausible cell types within the given tissue and treat highly anomalous markers as strong indicators of potential data quality issues or rare subtypes requiring further investigation. Let's revise the annotation with this feedback in mind. **Revised Step-by-Step Analysis:** **1. List the Key Functional Markers (from the provided ranked list, focusing on top markers):** * **NKAIN3:** Ion transport regulation. High expression suggests active cellular processes. * **SPP1 (Osteopontin):** Cell adhesion, ECM remodeling, immune modulation. Associated with mesenchymal cells, stem cells, and macrophages. * **PLP1 (Proteolipid Protein 1):** Major component of CNS myelin. **Highly anomalous for intestinal tissue.** * **L1CAM:** Cell adhesion, neurite outgrowth. Found in neurons and some stem/progenitor cells. * **MYOT:** Muscle protein. Unexpected in this context. * **IGSF11:** Cell adhesion, signaling. * **NRXN1:** Synaptic adhesion molecule. Primarily neuronal. * **SOX10:** Transcription factor for neural crest derivatives (glia, melanocytes). Strong glial marker. * **MEGF10:** Cell adhesion, signaling. * **SYT10:** Calcium signaling, vesicle trafficking. * **CADM2:** Cell adhesion. * **SLITRK2:** Neurite outgrowth. * **SOX2:** Stem cell transcription factor. * **CRTAC1:** ECM component. * **CHL1:** Neural adhesion/development. * **ZNF536:** Transcription factor. * **FOXD3:** Neural crest progenitor transcription factor. * **PTPRZ1:** Neural adhesion, signaling. * **GRIK3:** Glutamate receptor subunit. Neuronal. * **TUBB2B:** Beta-tubulin. Neuronal cytoskeleton. * **CMTM5:** Cell migration, immune. * **TTYH1:** Ion channel. * **ADARB2:** RNA editing. * **CDH2 (N-Cadherin):** Cell adhesion. Mesenchymal/neuronal. * **TENM3:** Neural adhesion, axon guidance. * **WNT6:** Wnt signaling pathway. * **ATP1A2:** Na+/K+-ATPase. Ion transport. * **NRXN3:** Synaptic adhesion molecule. Primarily neuronal. * **KCNMB4:** Potassium channel subunit. * **TMEM132B:** Cell adhesion, signaling. * **LPL:** Lipid metabolism enzyme. Endothelial, adipocyte, macrophage. * **GFRA2:** GDNF receptor. Neuronal survival/differentiation. * **CHADL:** ECM component. * **FLRT1:** Neural adhesion/development. * **CHST9:** Glycosylation. * **GJC3:** Gap junction protein. * **RHAG:** Amino acid transporter. * **FOXD3-AS1:** Antisense RNA. **2. List the Key Cell Type Markers (focusing on biologically plausible context):** * **Neural Crest / Glial / Progenitor Markers:** * **SOX10:** Strong glial marker, neural crest derivative. High rank. * **SOX2:** Stem/progenitor marker. High rank. * **FOXD3:** Neural crest progenitor marker. High rank. * **PLP1:** **Anomalous marker.** Primarily oligodendrocyte (CNS myelin). Its high rank is a critical flag. * **L1CAM, CHL1:** Neural adhesion/development. High rank. * **GFRA2, FLRT1:** Neural development/signaling. High rank. * **PTPRZ1:** Neural adhesion/signaling. High rank. * **Mesenchymal / ECM Markers:** * **SPP1:** Mesenchymal stem cell, ECM. High rank. * **CDH2:** Mesenchymal/neuronal adhesion. High rank. * **CHADL, CRTAC1:** ECM components. * **Neuronal Markers:** * **NRXN1, NRXN3:** Synaptic adhesion. High rank. * **SLITRK2, TENM3:** Neurite outgrowth, axon guidance. High rank. * **GRIK3, TUBB2B:** Neuronal function/cytoskeleton. * **Ion Transport Markers:** * **NKAIN3, ATP1A2:** Ion transport. Very high rank. **3. Cross-reference Known Databases (Prioritizing biological plausibility):** The presence of **SOX10**, **SOX2**, **FOXD3**, **L1CAM**, **CHL1**, **NRXN1**, **NRXN3**, **SLITRK2**, **TENM3**, **GFRA2**, **FLRT1**, **PTPRZ1**, **SPP1**, and **CDH2** strongly suggests a **neural crest-derived cell population** within the large intestine. This aligns well with the known presence of enteric neurons and enteric glial cells, as well as potential mesenchymal progenitors in the gut. The high ranking of **NKAIN3** and **ATP1A2** indicates active ion transport, consistent with glial cells, neurons, or even some epithelial cells. The high ranking of **SPP1** and **CDH2** suggests potential mesenchymal characteristics or a progenitor state. The critical anomaly is **PLP1**. Its presence as a top-ranked marker is highly inconsistent with intestinal tissue. Standard databases and literature overwhelmingly associate PLP1 with oligodendrocytes in the CNS. Its presence here is a major red flag for potential **sample contamination with CNS tissue**. **4. Determine the Most Probable General Cell Type:** Given the tissue is the **large intestine**, the most biologically plausible cell types indicated by the majority of the high-ranking markers (SOX10, SOX2, FOXD3, L1CAM, NRXN1, SPP1, CDH2) are **neural crest-derived cells**. This encompasses enteric glial cells, enteric neural progenitors, and potentially some mesenchymal-like cells. However, the extremely high ranking of **PLP1** cannot be ignored. It strongly suggests either: a) **Significant cross-contamination with CNS tissue.** b) A very rare, previously undocumented subtype of enteric glia or neural progenitor that aberrantly expresses PLP1. Prioritizing biological plausibility and the principle of parsimony (Occam's Razor), **sample contamination is the most likely explanation for the high PLP1 expression.** Therefore, the cluster likely represents a population of **enteric glial cells** or **enteric neural progenitors** that are either: i) Contaminated with CNS tissue (specifically oligodendrocytes or their precursors). ii) A rare subtype with unusual marker expression. Without further information to rule out contamination, the most prudent approach is to identify the most plausible intestinal cell type while flagging the anomaly. **5. Identify the Top 3 Most Probable Sub Cell Types:** Given the strong evidence for neural crest derivatives and the intestinal context, while acknowledging the PLP1 anomaly: 1. **Enteric Glial Cells (with potential PLP1 anomaly):** * **Supporting Markers:** **SOX10** (strong glial marker, high rank), **SOX2**, **FOXD3**, **NKAIN3**, **ATP1A2**, **SPP1**, **CDH2**, **L1CAM**, **CHL1**, **NRXN1**, **GFRA2**, **FLRT1**, **PTPRZ1**. The presence of **PLP1** is noted as a significant anomaly. * **Reasoning:** SOX10 is a canonical marker for enteric glia. The co-expression of SOX2, FOXD3, SPP1, CDH2, and various neural markers fits well with enteric glial cells or their progenitors. The high expression of ion transporters is also consistent. The PLP1 expression is highly unusual and requires further investigation, potentially indicating contamination or a rare subtype. 2. **Enteric Neural Progenitor Cells:** * **Supporting Markers:** **SOX2** (strong progenitor marker, high rank), **SOX10**, **FOXD3**, **L1CAM**, **CHL1**, **NRXN1**, **NRXN3**, **SLITRK2**, **TENM3**, **SPP1**, **CDH2**, **WNT6**. **PLP1** anomaly noted. * **Reasoning:** The co-expression of SOX2, SOX10, and FOXD3 strongly supports a progenitor population capable of differentiating into neurons and glia. SPP1 and CDH2 also fit a progenitor state. The neuronal markers indicate differentiation potential. PLP1 remains an anomaly. 3. **Mesenchymal Stem Cells / Stromal Cells (with neural crest characteristics):** * **Supporting Markers:** **SPP1** (high rank), **CDH2** (high rank), **SOX2**, **SOX10**, **CHADL**, **CRTAC1**, **LPL**. **PLP1** anomaly noted. * **Reasoning:** High expression of SPP1 and CDH2 points towards a mesenchymal origin. SOX2 and SOX10 can be expressed by some mesenchymal progenitor populations. LPL expression could also be present in stromal cells. However, the strong neural crest markers (SOX10, FOXD3, L1CAM etc.) make this less likely than glial/neural progenitor cells unless it's a specific neural crest-derived mesenchymal population. **Most Likely Subtype:** Considering the biological context of the large intestine and the majority of high-ranking markers, the most likely cell type is **Enteric Glial Cells**. The strong SOX10 expression, coupled with SOX2, FOXD3, and various neural/progenitor markers, supports this. The high expression of SPP1 and CDH2 could indicate a progenitor state or a specific subtype of enteric glia with mesenchymal characteristics. **Crucially, the high ranking of PLP1 must be flagged as a significant anomaly, strongly suggesting potential cross-contamination with CNS tissue.** If contamination is ruled out, then this cluster might represent a rare enteric glial subtype with atypical PLP1 expression, but this would require substantial further investigation and literature support. **6. Provide a Concise Summary of Your Analysis:** The provided ranked marker list from a large intestine dataset reveals a population of **neural crest-derived cells**, most likely **Enteric Glial Cells**. This is supported by the high expression of canonical glial and progenitor markers (**SOX10, SOX2, FOXD3**) and numerous neuronal development genes (**L1CAM, NRXN1, CHL1, GFRA2, FLRT1, PTPRZ1**). High expression of **SPP1** and **CDH2** suggests potential mesenchymal characteristics or a progenitor state. However, the presence of **PLP1** as a top-ranked marker is a significant anomaly, as PLP1 is a definitive marker for oligodendrocytes (CNS myelinating glia) and is not typically found in the intestine. This strongly suggests **potential cross-contamination with CNS tissue**. Therefore, the primary annotation is **Enteric Glial Cells**, with the strong caveat that the PLP1 expression indicates a need to rigorously investigate sample integrity. If contamination is ruled out, further research would be needed to characterize this as a rare enteric glial subtype. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Enteric Glial Cells"", ""sub_cell_types"": [ ""Enteric Glial Cells (with potential PLP1 anomaly)"", ""Enteric Neural Progenitor Cells"", ""Mesenchymal Stem Cells / Stromal Cells (with neural crest characteristics)"" ], ""possible_mixed_cell_types"": [ ""Contamination with CNS tissue (specifically oligodendrocytes or their precursors)"" ] } ```"
plasma cell,Plasma Cells,"IgA-producing Plasma Cells, IgG-producing Plasma Cells, IgM-producing Plasma Cells",,50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash-lite,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type and subtype from the provided marker list: **1. List the Key Functional Markers:** * **Immunoglobulin Synthesis/Antibody Production:** * `IGLL5`, `IGLV6-57`, `IGLC3`, `IGLC2`, `IGKV4-1`, `IGKV1-5`, `IGLV3-1`, `IGLV2-11`, `IGKV3-20`: These are all immunoglobulin light chain variable and constant region genes. Their expression strongly indicates a role in antibody production. * `JCHAIN`: This gene encodes the joining chain, a critical component for the polymerization of IgM and IgA into pentameric and dimeric forms, respectively. This is a hallmark of B cell differentiation, particularly plasma cells. * `IGHV3-7`, `IGHV3-23`, `IGHV3-74`: These are immunoglobulin heavy chain variable region genes. Their presence further supports B cell lineage and antibody diversification. * `IGHG1`, `IGHG3`, `IGHM`, `IGHA1`, `IGHA2`: These are immunoglobulin heavy chain constant region genes, representing different antibody isotypes (IgG, IgM, IgA). Their expression signifies active antibody secretion. * `TNFRSF17` (BCMA): This is a receptor for BAFF and APRIL, crucial for B cell survival and differentiation, particularly plasma cell maturation. * `MZB1`: This gene encodes a protein involved in the endoplasmic reticulum-Golgi transport of immunoglobulins. It's highly expressed in plasma cells. * `FCRL5`: Fc receptor-like 5, a B cell-specific surface receptor involved in B cell activation and differentiation. * **Cellular Stress/Response:** * `TXNDC5`: Thioredoxin domain-containing protein 5, involved in protein folding and oxidative stress response, often upregulated in antibody-secreting cells due to high protein synthesis load. * `AMP D1`: Adenosine monophosphate deaminase 1, involved in purine metabolism and cellular energy, can be associated with metabolic demands of active cells. * **Chemotaxis/Inflammation:** * `CCL3` (MIP-1Î±): A chemokine involved in recruiting immune cells, can be expressed by various immune cells, including activated B cells and plasma cells. * `CCR10`: A receptor for CCL27 and CCL28, involved in T cell and B cell homing to skin and mucosal tissues. * **Other:** * `MYL2`: Myosin light chain 2, a component of the contractile apparatus, its presence here is less typical for plasma cells and might indicate some degree of cellular motility or a specific subtype. * `LILRB4`: Leukocyte immunoglobulin-like receptor B4, expressed on monocytes, dendritic cells, and some B cell subsets. **2. List the Key Cell Type Markers:** * **B Cell/Plasma Cell Specific:** * `IGLL5`, `IGLV6-57`, `IGLC3`, `IGLC2`, `IGHV3-7`, `IGHG1`, `IGHG3`, `IGHM`, `IGHA1`, `IGHA2`, `IGKV4-1`, `IGKV1-5`, `IGLV3-1`, `IGLV2-11`, `IGKV3-20`, `JCHAIN`, `TNFRSF17`, `MZB1`, `FCRL5`, `IGHV3-23`, `IGHV3-74`. These are overwhelmingly indicative of B lineage cells, specifically those involved in antibody production. The high expression of `JCHAIN`, `TNFRSF17`, and `MZB1` strongly points towards a plasma cell phenotype. * **Potential Non-B Cell Markers (less dominant):** * `LILRB4`: Can be found on myeloid cells and some B cells. * `CCL3`, `CCR10`: Expressed by various immune cells, including B cells. * `MYL2`: Typically associated with muscle cells, but can be found in other cell types with contractile functions or as a less specific marker. **3. Cross-reference Known Databases:** * **Human Protein Atlas (HPA):** * `JCHAIN`: Highly expressed in plasma cells. * `MZB1`: Highly expressed in plasma cells. * `TNFRSF17` (BCMA): Highly expressed in plasma cells. * `IGLC3`, `IGLC2`, `IGKV4-1`, `IGKV1-5`, `IGLV3-1`, `IGLV2-11`, `IGKV3-20`, `IGHG1`, `IGHM`, `IGHA1`, `IGHA2`, `IGHV3-7`, `IGHV3-23`, `IGHV3-74`, `IGLL5`, `IGLV6-57`: All are components of immunoglobulins and are expected in B cells and plasma cells. * `FCRL5`: Expressed in B cells, particularly memory B cells and plasma cells. * `CCL3`: Expressed in various immune cells, including activated B cells. * `LILRB4`: Expressed in monocytes, dendritic cells, and some B cell subsets. * **PanglaoDB:** * `JCHAIN`: Marker for Plasma cells. * `MZB1`: Marker for Plasma cells. * `TNFRSF17`: Marker for Plasma cells. * `IGHA1`, `IGHA2`, `IGHG1`, `IGHM`, `IGLC3`, `IGKV1-5`, `IGKV4-1`, `IGLV3-1`: Markers for various B cell subsets and Plasma cells. * `FCRL5`: Marker for B cells, Memory B cells, Plasma cells. * `CCL3`: Marker for Monocytes, Macrophages, NK cells, T cells, B cells. * `LILRB4`: Marker for Monocytes, Dendritic cells, B cells. * **scRNA-seq Literature (General Knowledge):** * The combination of high expression of immunoglobulin genes (heavy and light chains), `JCHAIN`, `TNFRSF17`, and `MZB1` is a canonical signature of **plasma cells**. These cells are terminally differentiated B cells specialized in antibody secretion. * `CCR10` is known to be expressed by B cells that home to mucosal sites, including the gut. * `LILRB4` can be expressed by certain B cell subsets, including antibody-secreting cells. **4. Determine the Most Probable General Cell Type:** Based on the overwhelming expression of immunoglobulin genes (heavy and light chains), `JCHAIN`, `TNFRSF17`, and `MZB1`, the most probable general cell type is **Plasma Cells**. These markers are highly specific and indicative of the terminal differentiation stage of B lymphocytes dedicated to antibody production. **5. Identify the Top 3 Most Probable Sub Cell Types:** Given the general cell type is Plasma Cells, we look for markers that might further refine this population. * **Top Candidate Subtypes:** 1. **IgA-producing Plasma Cells:** * **Supporting Markers:** `IGHA1`, `IGHA2` (IgA heavy chains), `JCHAIN` (essential for IgA polymerization into dimeric IgA). The presence of IgA isotypes is a strong indicator. * **Contextual Relevance:** The large intestine is a major site for IgA production, as IgA is the primary antibody isotype found in mucosal secretions. 2. **IgG-producing Plasma Cells:** * **Supporting Markers:** `IGHG1`, `IGHG3` (IgG heavy chains). * **Contextual Relevance:** IgG is also present in serum and can be found at mucosal sites, though IgA is dominant in the gut lumen. 3. **IgM-producing Plasma Cells:** * **Supporting Markers:** `IGHM` (IgM heavy chain), `JCHAIN` (essential for IgM polymerization into pentameric IgM). * **Contextual Relevance:** While IgM is the first antibody produced during an immune response, its presence as a dominant isotype in terminally differentiated plasma cells in the large intestine might be less common compared to IgA, but still possible. * **Most Likely Subtype:** The most likely subtype is **IgA-producing Plasma Cells**. This is strongly supported by the high expression of `IGHA1` and `IGHA2`, along with `JCHAIN`, and the tissue context (large intestine), which is a primary site for IgA secretion. While IgG and IgM plasma cells are also possible, the prominence of IgA markers makes this subtype the most probable. **6. Provide a Concise Summary of Your Analysis:** The provided list of highly expressed genes is dominated by immunoglobulin heavy and light chain genes (`IGH` and `IGL`/`IGK`), the joining chain (`JCHAIN`), and key plasma cell markers like `TNFRSF17` (BCMA) and `MZB1`. This molecular signature is highly characteristic of **Plasma Cells**, which are terminally differentiated B lymphocytes responsible for antibody secretion. Within the plasma cell population, the strong expression of `IGHA1` and `IGHA2` alongside `JCHAIN`, in the context of the large intestine tissue, points towards **IgA-producing Plasma Cells** as the most probable subtype. These cells are crucial for mucosal immunity in the gut. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Plasma Cells"", ""sub_cell_types"": [ ""IgA-producing Plasma Cells"", ""IgG-producing Plasma Cells"", ""IgM-producing Plasma Cells"" ], ""possible_mixed_cell_types"": [] } ```"
